Zydus Cadila has received emergency use approval from the Indian regulator for the use of its anti-viral drug 'Virafin'. Pharma giant Zydus says 91.15 per cent of adult patients treated with Virafin tested negative using RT-PCR in seven days. Virafin helps body cope with Interferon Alpha deficiency In its Phase III clinical trials, researchers found that a higher proportion of …
Zydus Cadila's Pegylated Interferon alpha-2b drug, 'Virafin', has received Emergency Use Approval from DCGI, the Drugs Controller General of India. Pharma giant Zydus Cadila says its anti-viral drug Virafin can not only reduce the need for medical oxygen but also improve recovery time among Covid-19 patients. Earlier launched as PegiHep, the drug was being used to treat Hepatitis C. A …
